Board MeetingAug 5, 2026, 08:05 AM
Ascentage Pharma Schedules H1 2026 Interim Results Release
AI Summary
Ascentage Pharma Group International announced it will release its six months 2026 unaudited interim results and provide business updates on August 19, 2026. The company will host an investor webcast with Q&A on the same day at 9:00 am EDT. Additionally, Chinese and English language investor conference calls and webcasts are scheduled for August 19 and August 20, 2026, respectively, to discuss the results.
Key Highlights
- Ascentage Pharma to release six months 2026 unaudited interim results on August 19, 2026.
- Investor webcast with Q&A scheduled for August 19, 2026, at 9:00 am EDT / 9:00 pm HKT.
- Chinese (Mandarin) language investor webcast at 9:00 pm EDT on August 19, 2026 / 9:00 am HKT on August 20, 2026.
- English language investor conference call and webcast at 8:00 am EDT / 8:00 pm HKT on August 20, 2026.
Price Impact
More from AAPG